Gene Query: ZBED1

Dataset Description Geneva Score
RNA sequencing of GlyH-101-treated MCF-7 cell line 37.94
Cajal bodies are linked to genome conformation 32.89
Cajal bodies are linked to genome conformation [RNA-Seq] 32.89
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 30.92
EP400 is required for Max and MCPyV mediated gene activation 29.73
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 29.54
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 27.6
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 27.41
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 26.6
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 25.9
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 25.07
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 24.44
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 21.7
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 20.39
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 19.76
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 19.76
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 19.58
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 18.78
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 18.76
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 17.81
snRNAs as regulators of alternative splicing 17.38
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 16.93
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 16.34
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 16.32
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 16.32
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 16.28
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 16.18
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 16.11
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 15.98
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 15.98
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 15.82
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 15.82
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 15.81
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 15.79
Seletive inhibition of CDK9 in DLBCL cell lines 15.33
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 15.32
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 15.11
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 15.0
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 15.0
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 14.6
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 14.18
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 14.11
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 14.07
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.83
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 13.74
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 13.27
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 13.13
Transcription control by the ENL YEATS domain in acute leukemia 13.13
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 12.99
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 12.75
Effect of drugs on transcriptomic profiles 12.72
RNA-seq of YB5 cells treated with Proscillaridin A 12.53
The evolution of N6-methyladenosine in primates 12.41
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.35
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.35
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 12.29
IDH3a KO RNA-seq 12.22
Effect of FGF13 depletion on the H460 cell line 12.03
Macrophage Ad5f35 M2 Challenge 11.8
ZIKV infection of monocytes activates inflammasome pathways 11.72
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 11.63
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 11.62
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 11.58
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 11.49
Uridylation by TUT4 and TUT7 marks mRNA for degradation 11.46
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 11.4
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 11.3
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 11.27
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 11.13
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 11.06
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 11.06
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 11.03
Mitochondrial dsRNA triggers antiviral signalling in humans 10.76
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 10.72
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 10.68
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 10.68
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 10.68
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 10.63
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.61
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.58
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 10.39
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 10.29
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 10.02
Transcriptional changes in lymphoma cells induced by LSD1 depletion 10.02
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 10.02
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 9.94
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.93
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 9.78
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 9.77
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 9.71
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 9.71
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 9.67
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 9.66
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 9.62
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 9.51
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 9.5
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 9.46
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 9.41
Human embryonic stem cells in E8 and AKIT culture medium 9.41
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 9.26
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 9.21
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 9.21
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 9.2
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.2
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 9.17
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 9.09
Silencing p300 in MCF7 cells to study expression and alternative splicing 9.06
RNA sequencing of primary human platelets and in vitro cell lines 9.03
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.99
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.99
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 8.98
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 8.98
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 8.98
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 8.96
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 8.88
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.82
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 8.78
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 8.78
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 8.73
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 8.69
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 8.53
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 8.38
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 8.33
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 8.28
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 8.28
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 8.26
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.2
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.2
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 8.16
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 8.13
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 8.13
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 8.08
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 7.97
NRDE2 negatively regulates nuclear exosome functions 7.92
RNAseq of T-ALL upon long non coding rna purturbation 7.85
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.83
Lysine benzoylation is a novel histone mark 7.83
Lysine benzoylation is a novel histone mark [RNA-seq] 7.83
hnRNP C is a key regulator of protein synthesis in mitosis 7.79
The comparison of high-throughput single-cell RNA-seq methods 7.78
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 7.69
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 7.69
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 7.64
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.61
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.56
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 7.51
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.48
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.43
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.38
BI Human Reference Epigenome Mapping Project 7.38
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 7.37
R430: A potent inbibitor of DNA and RNA viruses 7.37
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.34
Human HAP1 cells before and after nutrient deprivation 7.31
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 7.31
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 7.2
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 7.18
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.1
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.1
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 7.08
HNRNPL and its RNA Targets in Prostate Cancer 7.08
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.07
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 7.04
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 6.99
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 6.93
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.92
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.9
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 6.89
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 6.89
Novel Targeting of Transcription and Metabolism in Glioblastoma 6.86
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 6.83
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.8
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.79
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 6.73
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 6.73
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.73
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 6.71
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.58
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.58
Lipid degradation promotes prostate cancer cell survival 6.54
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 6.52
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.52
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 6.39
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 6.38
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 6.37
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 6.37
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.33
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.33
U1 snRNP telescripting regulates size-function stratified human genome 6.32
Macrophage Ad5f35 PhenoMap 6.28
Genome-wide discovery of human splicing branchpoints 6.23
Effects of rFVIIIFc on human macrophages 6.22
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 6.18
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 6.18
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 6.18
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.17
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.17
HNRNPM-regulated splicing dependencies in prostate cancer 6.15
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 6.15
Nutritional control of protein translation 6.15
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.11
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 6.05
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.05
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.04
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.03
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.02
Gene expression changes upon drug withdrawal (Mel888 cell line) 5.91
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 5.91
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 5.9
Landscape and variation of RNA secondary structure across the human transcriptome 5.88
Gene expression profiling of leukemia cells following asparagine depletion 5.86
Primary human trophoblast from term placenta 5.86
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.84
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 5.83
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 5.82
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 5.81
CHD1 regulates cell fate determination by activation of differentiation-induced genes 5.8
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 5.78
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.74
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.73
Studying the selectivity of a small molecule Synucleozid on transcriptome 5.73
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 5.73
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.71
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 5.71
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 5.71
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.7
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.68
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 5.67
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 5.64
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 5.63
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 5.62
Global epigenomic reconfiguration during mammalian brain development 5.62
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.61
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 5.54
Evaluating pre-clinical models for studying NASH driven HCC. 5.51
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.5
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 5.5
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.48
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.48
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 5.46
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 5.45
Regulation of Lipids is Central to Replicative Senescence 5.4
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.4
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 5.4
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 5.4
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 5.36
Primate transcript and protein expression levels evolve under compensatory selection pressures 5.33
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 5.28
X-Ray induced DNA-Hydroxymethylation changes 5.22
Transcriptome analysis of CNS leukemia 5.15
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 5.15
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 5.13
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 5.09
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 5.09
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 5.09
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.05
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.04
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 5.03
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 5.01
ADAR1-editing of cellular and measles virus-derived duplex RNA 4.96
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 4.96
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 4.94
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 4.91
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.9
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.87
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.85
SF3B1 Degron knockdown RNA-seq 4.85
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 4.82
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.8
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.8
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.79
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.79
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.79
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 4.73
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 4.72
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.64
Functional significance of the HIV-1 Tat signature amino acid residues 4.62
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.6
Efficient derivation of microglia-like cells from human pluripotent stem cells 4.6
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.59
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 4.58
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 4.58
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.55
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.54
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 4.51
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 4.51
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 4.5
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.49
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 4.49
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 4.46
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 4.44
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 4.44
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 4.42
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 4.42
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 4.4
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 4.39
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.36
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 4.31
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 4.23
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 4.23
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 4.21
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 4.21
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 4.2
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.16
Transcriptome wide analysis of classically and alternatively activated macrophages 4.15
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.14
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.13
PTHrP overexpression in MCF7 cells 4.11
Mapping interactions for the TNIP2 hub protein 4.09
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 4.03
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 4.02
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.99
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 3.96
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 3.93
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 3.93
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 3.9
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.84
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.81
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.75
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.75
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.74
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.73
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 3.73
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 3.72
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.62
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 3.62
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 3.62
miRNAs affected by antagomiR-17 treatment 3.52
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.51
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.51
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.48
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.47
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.45
Subtle asymmetry of gene expression in embryonic and foetal human brains 3.43
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 3.43
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.43
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 3.42
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 3.38
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 3.35
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.33
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 3.31
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 3.31
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.25
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.22
Disruption of GRIN2B impairs differentiation in human neurons 3.21
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 3.18
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 3.17
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.15
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 2.95
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 2.95
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 2.94
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.91
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 2.88
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 2.87
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.84
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.77
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.76
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.76
Metabolism as an early predictor of DPSCs aging 2.72
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.69
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.68
The cohesin release factor WAPL restricts chromatin loop extension. 2.64
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.64
Modeling Human Cancer-induced Cachexia (Human) 2.63
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.63
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 2.53
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.48
RNA seq_PDX2_SHP099 2.47
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.47
Dermal endothelial cells of type 2 diabetic patients 2.47
Glioblastoma stem cells infected by ZIKA virus 2.45
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.44
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.42
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.36
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.36
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 2.34
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.33
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 2.24
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 2.24
Energy Metabolism during Anchorage-Independence 2.22
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 2.19
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 2.19
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.12
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.07
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.07
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 2.06
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.02
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.99
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 1.98
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.97
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.93
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.83
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.8
Exploring ILF2 regulatory genes by next-generation sequencing 1.75
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.75
Genome-wide discovery of human splicing branchpoints [RNAse] 1.7
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.7
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.7
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.67
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.67
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.61
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.61
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 1.6
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 1.6
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.56
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 1.55
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.52
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.51
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.49
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.47
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.46
The role of m6A/m-RNA methylation in stress response regulation 1.46
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 1.46
m6A-dependent regulation of messenger RNA stability 1.43
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.42
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 1.42
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.4
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.39
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.38
Determining mRNA half-lives on a transcriptome-wide scale 1.37
Gene expression analysis upon mtDNA depletion 1.37
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.37
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.34
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.34
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.33
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.32
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 1.26
The Genetic Landscape of Diamond-Blackfan Anemia 1.25
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 1.23
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.23
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.22
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.2
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.19
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.17
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.17
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 1.14
Differential responses of human fetal brain neural stem cells to Zika virus infection 1.13
quanTIseq: quantifying immune contexture of human tumors 1.06
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 1.04
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 1.01
MicroRNA targetome analysis during HCMV infection 1.0
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.99
Enhancer activation during EGF response 0.98
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 0.93
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.9
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.87
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.86
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.85
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 0.82
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 0.82
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.81
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.77
Trascriptome of thyroid cancer-induced macrophages 0.76
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.76
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.73
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.7
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.66
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.66
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.65
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.63
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.61
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.6
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.54
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.54
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.53
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.53
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.53
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.52
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.5
SOX11 knockdown in B-ALL cell lines 0.49
KSDM1b Role in Ewing Sarcoma 0.45
Transcriptome of activated human and mouse MAIT cells 0.41
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.38
Epigenomic conservation of transposable element silencing 0.37
Epigenomic conservation of transposable element silencing [RNA-seq] 0.37
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.37
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.37
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.37
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.36
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 0.35
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.35
The pioneer factor CEBPA modulates vitamin D signaling 0.33
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.33
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.32
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.31
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.26
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.24
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.24
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.22
Discovering human diabetes-risk gene function with genetics and physiological assays 0.14
Specific molecular signatures underlie response to decitabine in CMML 0.1
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.1
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.09
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.08
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.08
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 0.06
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 0.05
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.05
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.01
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation